ArticleJournal of clinical medicine2023

Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis.

Riccardo Proietti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.